SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-053209
Filing Date
2018-08-22
Accepted
2018-08-22 16:25:00
Documents
8
Period of Report
2018-09-13
Effectiveness Date
2018-08-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-18674_1def14a.htm DEF 14A 258174
2 GRAPHIC g186741bgi001.gif GRAPHIC 2996
3 GRAPHIC g186741bei001.jpg GRAPHIC 3981
4 GRAPHIC g186741bsi001.jpg GRAPHIC 104762
5 GRAPHIC g186741bsi002.jpg GRAPHIC 90482
6 GRAPHIC g186741boi001.gif GRAPHIC 2496
7 GRAPHIC g186741bci001.jpg GRAPHIC 3804
8 GRAPHIC g186741bci002.gif GRAPHIC 2809
  Complete submission text file 0001104659-18-053209.txt   551281
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 0131
Type: DEF 14A | Act: 34 | File No.: 001-33818 | Film No.: 181032749
SIC: 3845 Electromedical & Electrotherapeutic Apparatus